PRESS RELEASE published on 11/07/2023 at 17:01, 1 year ago EQS-Adhoc: Allgeier SE continues its transformation towards more added value in the first nine months of 2023
PRESS RELEASE published on 08/23/2023 at 11:40, 1 year 2 months ago Allgeier SE: SDX, a Microsoft specialist in cloud software development and data analytics, joins the Allgeier Group
PRESS RELEASE published on 08/03/2023 at 19:55, 1 year 3 months ago EQS-Adhoc: Allgeier SE increases sales by 6 percent and value added by 12 percent in the first half of 2023
PRESS RELEASE published on 06/22/2023 at 18:30, 1 year 4 months ago Allgeier SE: Allgeier provides clarification
PRESS RELEASE published on 05/11/2023 at 10:40, 1 year 6 months ago EQS-Adhoc: Allgeier SE: Allgeier achieves double-digit growth in the first quarter of 2023
PRESS RELEASE published on 03/09/2023 at 12:07, 1 year 8 months ago EQS-Adhoc: Allgeier SE increases total performance by 21% in fiscal year 2022 – earnings margin rises disproportionately
Published on 11/21/2024 at 14:00, 13 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 13 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 13 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 43 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 38 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 58 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 15 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 53 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 28 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 28 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
